TeleDaaS™ Launches Y90 Treatment Planning Service and Announces Pilot Program for Early Adopters
March 25, 2024 08:02 ET
|
TeleDaas PLLC
TeleDaaS™ Launches Y90 Treatment Planning Service and Announces Pilot Program for Early Adopters
TeleDaaS™ Launches as Premier Provider of Dosimetry as a Service for Clinical Research Organizations
November 26, 2023 08:00 ET
|
TeleDaas PLLC
TeleDaaS revolutionizes radiopharmaceutical research by delivering highly-scalable, clinical-grade dosimetry to accelerate cancer treatment breakthroughs.
Insights on the Thermoluminescent Dosimeter Services Global Market to 2027 - Upsurge in Number of Nuclear Power Plants to Meet Energy Demands Presents Opportunities
August 29, 2022 06:48 ET
|
Research and Markets
Dublin, Aug. 29, 2022 (GLOBE NEWSWIRE) -- The "Global Thermoluminescent Dosimeter (TLD) Services Market (2022-2027) by Type, Industry, Dosimetry Service, Geography, Competitive Analysis, and the...
IBA vend RadioMed, partie d’IBA Dosimétrie, à IZI Medical Products
December 17, 2019 01:00 ET
|
IBA SA
IBA vend RadioMed, partie d’IBA Dosimétrie, à IZI Medical Products Le reste de la division Dosimétrie restera au sein du groupe IBA. L’évaluation stratégique de cette division est maintenant...
IBA Press Release: IBA sells RadioMed, part of IBA Dosimetry, to IZI Medical Products
December 17, 2019 01:00 ET
|
IBA SA
IBA sells RadioMed, part of IBA Dosimetry, to IZI Medical Products Remainder of Dosimetry division retained, strategic review concluded Louvain-la-Neuve, Belgium, 17 December 2019 - IBA (Ion Beam...
IBA DÉCLARATION INTERMÉDIAIRE - TROISIÈME TRIMESTRE 2019
November 14, 2019 00:30 ET
|
IBA SA
Louvain-la-Neuve, Belgique, le 14 novembre 2019 - IBA (Ion Beam Applications S.A., EURONEXT), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, publie...
Iba Business Update – Third Quarter 2019
November 14, 2019 00:30 ET
|
IBA SA
Louvain-la-Neuve, Belgium, 14 November, 2019 - IBA (Ion Beam Applications SA), the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces its business update...
IBA annonce ses résultats du premier semestre 2019
August 22, 2019 01:00 ET
|
IBA SA
Hausse des revenus du groupe à hauteur de 13,8% pour atteindre EUR 102,8 millions, avec des revenus supérieurs attendus au second semestre 2019Position de leader confirmée sur le marché, tous secteurs...
IBA Reports Half Year Results for 2019
August 22, 2019 01:00 ET
|
IBA SA
Group revenue up 13.8% to EUR 102.8 million, with higher revenues expected over H2 2019Market leadership confirmed in all business lines and major geographiesTwo Proteus®ONE solutions sold in Italy...